PETAH TIKVA, Israel & BOCA RATON, Fla.--(BUSINESS WIRE)--Biobeat Technologies, Ltd., developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn ...
Add Yahoo as a preferred source to see more of our stories on Google. If just by looking at our watch or cell phone we can know, in real time, our heart rate, the number of steps we take, the calories ...
Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor Biobeat Technologies, Ltd., developer of the first ...
Biobeat Technologies, Ltd., developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment of ...
Cuff-based ABPM devices have historically been underutilized due to their frequent and disruptive inflation cycles resulting in low patient compliance and logistical device and data collection issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results